drugset / Trial / NCT06750458

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

NCT06750458

Phase 3 Not yet recruiting 75 enrolled Tanta University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study is to compare between the role of dapagliflozin versus dexamethasone in pre-operative management of non-diabetic glioma patients on levetiracetam as anti-seizure drug.

Timeline

Start
2025-08-20
Primary completion
2026-10-20
Completion
2026-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 10 mg
Comparator Dexamethasone Small molecule 8 mg

Indications